Open AccessIntestinal Mucormycosis in a Hemodialysis Patient Treated with Desferrioxamine
Author(s) -
Kaneko Takehiko,
Abe Fumihiko,
Lto Makoto,
Hotchi Masao,
Yamada Kazuhiko,
Okada Yohnchi
Publication year - 1991
Publication title -
acta patholigica japonica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 74
ISSN - 0001-6632
DOI - 10.1111/j.1440-1827.1991.tb02521.x
Subject(s) - mucormycosis , hemodialysis , medicine , pathology , deferoxamine , intensive care medicine
A case of fatal intestinal mucormycosis in a 57 year‐old female hemodialysis patient who had received desferrioxamine (DFO) for aluminum overload is reported. The focus of fungal infection was not found until the intestine had been resected surgically. DFO is being used with increased frequency in dialysis patients to treat aluminum or iron overload. Recently a possible link between DFO therapy and mucormycosis has been suggested. In the management of hemodialysis patients, the potential risk of mucormycosis with DFO therapy should be considered. Acta Pathol Jpn 41: 561–566, 1991.